The efficacy of radiation therapy of tumeurs depends on lethal effects on malignant cells but also on modifications of vessels and connective tissue (STENSTROMet coll. 1955 , PUCK & MARCUS1956, HEWITT & WILSON 1959 . Tumour irradiation induces an immune response of the host cooperating in the destruction of allogeneic malignant cells (DENEUFBOURG 1972 (DENEUFBOURG , 1975 . These preliminary findings were tested in an experiment system consisting of a chernically induced epidermoid carcinoma transplanted in a syngeneic situation. The influence of irradiation and active non-specifie immunotherapy was assessed in vivo on the level of concomitant immunity. The results are now reported.
Materials and Methods lnbred female CBA mice 2 to 3 months old were used. They were fed with standard pellet diet and water ad libitum. The experiment groups contained 30 to 40 mice for each data point.
An epidermoid carcinoma was induced by repeated painting of the skin with 20-methylcholantrene, and a syngeneic tumour was maintained by seriai subcutaneous transplantations. Tumour pieces aseptically prepared were inoculated intradermally in the median dorsal region of the animais. The tumour growth followed a linear progression and remained purely local without deep infiltration or visible metastases. Host mean survival time was about 30 days.
Irradiation was performed on day 8 of tumour growth. An original set-up of holding and shielding allowed a good exposure of the target volume without anesthesia (DENEUFBOURG1972). The irradiation was delivered through two parallel opposed portaIs and conferred single doses of 25 or 5 Gy at mid-depth. The radiation was generated with a Philips apparatus at 50 kV and 2 mA with a 1 mm AI filter and a focus-skin distance of 4 cm. The wholebody dose did not exceed one per cent of the tumour dose.
Active non-specifie immunotherapy. On day 8 of tumour growth 0.5 mg of a suspension of Corynebacterium parvum (2 mg/ml; kindly supplied by Institut Mérieux, Lyon, France) was injected intraperitoneally or subcutaneously in each animal.
Assessment of concomitant immunity. Three groups of mice (non-irradiated, irradiated, or after immunotherapy) bearing a dorsal tumour received a second intradermal tumour implant on their ventral side. This challenge graft contained about 10 6 tumour cells; it was observed 3 times weekly and rejections were recorded.
Results
Tumour growth. After a latent period of at least 3 days anti-tumour immunization rose to 31 per cent on day 6 and to 73 per cent on day 8. Then it Immunotherapy. After intraperitoneal administration of Corynebacterium parvum on day 8 of tumour growth concomitant immunity reached 65 per cent on day 10 and 75 per cent on day 15. Using the subcutaneous route the corresponding rejection rates were 54 per cent and 53 per cent, respectively.
Immunotherapy and irradiation. A 5 Gy tumour dose associated with intraperitoneal injection of Corynebacterium parvum induced an 88 per cent rejection rate of the challenge graft on day 10. Antitumour resistance evaluated on day 15 was present in 72 per cent of the mice. Results with adjuvant immunotherapy via the subcutaneous route were similar to the controls: 59 and 44 per cent, respectively.
Discussion
The efficacy of radiation therapy depends to a large extent on the lethal effects on tumour cells (PUCK& MARCUS,HEWITT& WILSON). Alterations of connective tissue and vascular modifications of the tumour bed are al~o known to play a part (STENSTROMet coll.).
Previously it was suggested that tumour irradiation induces an immune response of the host cooperating in the destruction of allogeneic malignant cells (DENEUFBOURG1972, 1975 . These preliminary results were confirmed in the present experiments using a chemically induced epidermoid carcinoma in a mou se syngeneic system. An antigenic tumour while progressively growing induces an immunization of the host against additional tumour isografts (BASHFORDet coll. 1908) . The level of this concomitant immunity reaches a maximum and then gradually declines as the primary tumour becomes larger (BARSKI & YOUN 1969 , DECKERSet coll. 1973 ). This phenomenon is related to several interacting factors: release of free antigen in excess, blockade by antigen-antibody complexes and production of suppressor lymphocytes and macrophages (BALDWINet coll. 1972 , THOMSON1975, POUPONet coll. 1976 ).
According to the present results, tumour irradia-347 tion reverses the vanishing phase of concomitant immunity. A 25 Gy single dose was effective within 48 ho urs and conferred anti-tumour resistance to 95 per cent of the animais 8 days later. This reaction was dose related. Data are still scarce in the literature about such immunologie effects. Fractionated tumour irradiation with a total dose of 90 to 120 Gy induced recovery of concomitant immunity in mice bearing a transplantable mammary tumour (BARSKI et coll. 1974) . Reappearance of immune resistance against a fibrosarcoma was observed after a tumour dose of 60 Gy but was delayed as long as vascular connections between host and tumour persisted (VAAGE 1973) . ln both reports it was noted that a comparable level of immunity was achieved after surgery and that an incomplete tumour resection prevented full recovery. ln the present system, irradiation did not lead to tumour elimination and yet reversed the decline of concomitant immunity without delay.
Mechanisms of radiation induced immune response are presently under investigation. Cell membrane destruction by irradiation is known to release antigenic material (MOROSON1978). Irradiation may induce antigenic modifications or unmasking and enhance host immunization (MARUYAMA1968). Untrapping of cytotoxic antibodies might also occur. Destruction of suppressor cells by whole-body exposure as a side-effect of tumour treatment is unlikely, due to the irradiation procedure.
Adjuvant active non-specifie immunotherapy with Corynebacterium parvum counteracted the decline of concomitant immunity associated with tumour progression. Immunostimulation was effective within 48 hours and lasted 8 days at least. The discrepancy of activity between intraperitoneal and subcutaneous injections (CASTRO 1977) was confirmed. Irradiation at low dosage and Corynebacterium parvum acted synergistically. An irradiation with 5 Gy is unable to modify the tumour host balance but potentiates non-specifie immunotherapy. Antigen availability may be a prerequisite for full range response to immunostimulation.
Detrimental immunosuppressive effects of radiation therapy have been pointed out especially in breast carcinoma treatment (STJERNSwARD1974). However, the relations are perhaps more complicated than are presumed. The present results ernphasize the fact that appropriate tumour irradiation and immunostimulation may also exert a beneficial influence on host resistance.
SUMMARY
Concomitant immunity was evaluated in vivo towards a chemically induced epidermoid carcinoma transplanted in a syngeneic situation. Radiation therapy reversed the decIining phase of concomitant immunity associated with tumour progression. The rejection rate of a challenge graft amounted to 82 and 95 per cent, respectively, 2 and 8 days after 25 Gy as compared with 55 and 43 per cent in unirradiated controls. Radiation induced immune recovery was dose related and proved to be different from restoration of immunity following surgical removal of the tumour. Immunotherapy with intraperitoneal injection of Corynebacterium parvum significantly improved concomitant immunity. Immunostimulation and irradiation at low dosage act synergistically on host anti-tumour resistance.
